Group II phospholipase a2 gene expression is transcriptionally regulated in rat liver during sepsis

American Journal of Physiology

Volumn 273, Issue 3 PART 1, 1997, Pages

  Dong, Lin Wang ^a,b   Yang, Jun ^a   Tong, Li Jia ^a   Hsu, Hseng Kuang ^a   Liu, Maw Shung ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Hepatic dysfunction; Septic shock; Transcriptional regulation

Indexed keywords

EID: 33745358326     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ausubel, F. M., R. Brents, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. Identification of newly transcribed RNA. In: Current Protocols in Molecular Biology, 1994, vol. 1, p. 4.10.1-4.10.11.
2. Ausubel, F. M., R. Brents, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. Immunoblotting and immunodetection. In: Current Protocols in Molecular Biology, 1994, vol. 2, p. 10.8.1-10.8.14.
3. Bush, H. Isolation and purification of nuclei. Methods Enzymol. 12:421-448, 1967.
4. Cerra, F. B. Multiple organ failure syndrome. In: Multiple Organ Failure, edited by D. J. Bihari and F. B. Cerra. Fullerton, CA: Soc. Grit. CareMed., 1989, p. 1-24.
5. 2. J. Biol. Chem. 269: 13057-13060, 1994.
6. 2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J. Clin. Invest. 97: 22332241, 1996.
7. 2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2. Infection 24: 103-108, 1996.
8. 2 using radioactive substrate. Anal. Biochem. 154: 676-681, 1986.
9. 2 expression in rat mesangial cell. J. Clin. Invest. 92: 2524-2532, 1993.
10. 2 in rat brain after severe forebrain ischemia and in endotoxic shock. Eur. J. Clin. Chem. Clin. Biochem. 34: 419-422, 1996.
11. 2 in rat brain after severe forebrain ischemia and in endotoxic shock. Brain Res. 651: 353-356, 1994.
12. Liu, M. S. Mechanisms of myocardial membrane alterations in endotoxin shock: roles of phospholipase and phosphorylation. Circ. Shock 30: 43-49, 1990.
13. Liu, M. S., S. Ghosh, and G. F. Kang. Mechanism of endotoxin induced reduction in the number of α drenergic receptors in dog livers: role of phospholipase A. Biochem. Med. 30: 295-304, 1983.
14. 2 in heart, liver and blood during endotoxin shock. J. Surg. Res. 45: 472-480, 1988.
15. Liu, M. S., and H. Takeda. Endotoxin-induced stimulation on phospholipase A activities in dog hearts. Biochem. Med. 28: 62-69, 1982.
16. Liu, M. S., and L. L. Wu. Heart sarcolemmal Ca2" transport in endotoxin shock. II. Mechanism of impairment in ATP-dependent Ca2 transport. Mol. Cell. Biochem. 112: 135-142, 1992.
17. Liu, M. S., and Y. T. Xuan. Mechanisms of endotoxin-induced impairment in Na VCa2 ' exchange in canine myocardium. Am. J. Physiol. 251 (Regulatory Integrative Comp. Physiol. 20): R1078R1085, 1986.
18. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
19. 2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid. FEBS Lett. 273: 23-26, 1990.
20. Nakano, T., O. Ohara, H. Teraoka, and H. Arita. Glucocorticoids suppress group II phospholipase A% production by blocking mRNA synthesis and post-transcriptional expression. J. BioL Chem. 265: 12745-12748, 1990.
21. 2 in hepatocytes in a patient with epitheloid hemangioendothelioma of the liver. Lab. Invest. 74: 585-591, 1996.
22. 2 in rat cultured astrocytes. J. Biol. Chem. 266: 9956-9960, 1991.
23. 2 activity by intravenous infusion of endotoxin in patients with neoplasia. J. Immunother. Emphasis Tumor Immunol. 12: 242-246, 1992.
24. Rodgers, J. R., M. L. Johnson, and J. M. Rosen. Measurement of mRNA concentration and mRNA half-life as a function of hormonal treatment. Methods Enzymol. 109: 572-592, 1985.
25. Sambrook, J., E. F. Fritsch, and T. Maniatis. Molecular Cloning (2nd ed.). Plainview, NY: Cold Spring Harbor Laooratory, 1989.
26. Thijs, L. G., and C. E. Hack. Time course of cytokine levels in sepsis. Intensive Care Med. 21, Suppl. 2:8258-8263, 1995.
27. 2 in the pathogenesis of the hemodynamic changes in endotoxin shock. Can. J. Physiol. Pharmacol. 61: 561-566, 1983.
28. 2 expression and pathogenesis of the sepsis syndrome. Circ. Shock 39: 160-167, 1993.
29. 2 enzyme activity and immunoactivity in a prospective analysis of patients with septic shock. Life Sci. 50: 807-811, 1992.
30. 2dependent signaling in the heart. Cardiovasc. Res. 30: 518-529, 1995.
31. 2 in rat renal mesangial cells. FEES Lett. 364: 218-222, 1995.
32. Wang, P., and I. H. Chaudry. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R927-R938, 1996.
33. Wichterman, K. A., A. E. Baue, and I. H. Chaudry. Sepsis and septic shock: a review of laboratory models and a proposal. J. Surg. Res. 29: 189-201, 1980.
34. Wu, L. L., and M. S. Liu. Altered ryanodine receptor of canine cardiac sarcoplasmic reticulum and its underlying mechanism in endotoxin shock. J. Surg. Res. 53: 82-90, 1992.